Variant report
Variant | rs4974639 |
---|---|
Chromosome Location | chr4:1099367-1099368 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAX | chr4:1099324-1099536 | H1-hESC | embryonic stem cell: | n/a | chr4:1099492-1099502 chr4:1099494-1099501 |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251639 | TF binding region |
ENSG00000251652 | Chromatin interaction |
ENSG00000178222 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10002248 | 0.88[CEU][hapmap] |
rs10002437 | 0.88[CEU][hapmap] |
rs10014245 | 0.88[CEU][hapmap] |
rs10032349 | 0.96[AFR][1000 genomes];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs10032470 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs10033163 | 1.00[CEU][hapmap];0.97[EUR][1000 genomes] |
rs11724989 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.83[EUR][1000 genomes] |
rs11728360 | 0.80[EUR][1000 genomes] |
rs11732259 | 0.81[EUR][1000 genomes] |
rs11732520 | 0.93[YRI][hapmap] |
rs11736950 | 0.83[EUR][1000 genomes] |
rs13119696 | 1.00[CEU][hapmap];0.83[YRI][hapmap];0.82[AFR][1000 genomes];0.97[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs1383660 | 1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs1466214 | 0.93[YRI][hapmap] |
rs1481167 | 0.88[CEU][hapmap];0.83[EUR][1000 genomes] |
rs1680027 | 0.85[AFR][1000 genomes];0.84[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs17164384 | 0.88[CEU][hapmap] |
rs1825092 | 0.91[AFR][1000 genomes];0.92[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs28374671 | 0.83[EUR][1000 genomes] |
rs28510738 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs28514301 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs28579427 | 0.81[EUR][1000 genomes] |
rs28588234 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs2924495 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs4246683 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs4246684 | 1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs4974561 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4974569 | 1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs4974571 | 1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs4974573 | 1.00[CEU][hapmap];0.93[YRI][hapmap] |
rs4974628 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4974637 | 0.97[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4974642 | 1.00[CEU][hapmap];0.93[YRI][hapmap];0.88[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4974643 | 1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs4974644 | 1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs55741287 | 0.83[AFR][1000 genomes] |
rs583100 | 0.85[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs584472 | 0.84[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs588824 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes];0.97[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs589660 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs59057706 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs604526 | 1.00[CEU][hapmap];0.83[YRI][hapmap];0.84[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs606293 | 0.85[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs606327 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs608066 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs614945 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.87[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs615381 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs616196 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs616569 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs617633 | 0.83[EUR][1000 genomes] |
rs619407 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs620398 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs629638 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs630549 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs632319 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs633087 | 1.00[CEU][hapmap];0.97[YRI][hapmap];0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs633141 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs633599 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.94[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs633954 | 1.00[CEU][hapmap];0.96[YRI][hapmap];0.87[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs636976 | 0.87[AFR][1000 genomes];0.87[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs643043 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs646117 | 0.91[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs647828 | 0.92[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs648640 | 0.92[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs649243 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs649258 | 0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs649616 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs649950 | 1.00[YRI][hapmap];0.91[AFR][1000 genomes];0.84[AMR][1000 genomes] |
rs651135 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs651509 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs658320 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs6599282 | 0.88[CEU][hapmap];0.80[EUR][1000 genomes] |
rs6599283 | 0.85[CEU][hapmap];0.83[EUR][1000 genomes] |
rs6599284 | 0.88[CEU][hapmap] |
rs661364 | 0.91[AFR][1000 genomes];0.95[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs671790 | 1.00[CEU][hapmap];0.82[EUR][1000 genomes] |
rs674347 | 0.84[AFR][1000 genomes];0.87[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs6814094 | 0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs6814276 | 0.83[EUR][1000 genomes] |
rs6817989 | 1.00[CEU][hapmap];0.83[EUR][1000 genomes] |
rs681857 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs682243 | 1.00[CEU][hapmap];0.97[YRI][hapmap];0.91[AFR][1000 genomes];0.97[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs682787 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes];0.95[AMR][1000 genomes];0.97[EUR][1000 genomes] |
rs6836158 | 0.88[CEU][hapmap] |
rs6839768 | 1.00[CEU][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.96[EUR][1000 genomes] |
rs6840162 | 1.00[CEU][hapmap];0.97[YRI][hapmap];0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs6852246 | 0.82[EUR][1000 genomes] |
rs687939 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs689216 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs73074169 | 0.86[AFR][1000 genomes];0.87[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs7676956 | 0.88[CEU][hapmap] |
rs7679718 | 0.88[CEU][hapmap] |
rs7686839 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs7690832 | 0.88[CEU][hapmap] |
rs7691553 | 0.99[AFR][1000 genomes];0.97[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs9992322 | 1.00[CEU][hapmap];0.81[EUR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv822425 | chr4:540105-1413799 | Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers ZNF genes & repeats Strong transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 108 gene(s) | inside rSNPs | diseases |
2 | nsv530490 | chr4:614355-1399150 | Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers ZNF genes & repeats Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 104 gene(s) | inside rSNPs | diseases |
3 | nsv1003219 | chr4:769894-1105464 | Strong transcription Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
4 | nsv536980 | chr4:827866-1167377 | Active TSS Weak transcription Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 40 gene(s) | inside rSNPs | diseases |
5 | nsv1009619 | chr4:901897-1215657 | Strong transcription Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 43 gene(s) | inside rSNPs | diseases |
6 | nsv1003876 | chr4:927509-1191316 | Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription Active TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 37 gene(s) | inside rSNPs | diseases |
7 | nsv1000381 | chr4:927509-1198766 | Weak transcription Enhancers Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
8 | esv3339080 | chr4:970630-1546223 | Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 82 gene(s) | inside rSNPs | diseases |
9 | nsv1004727 | chr4:1015652-1158207 | Enhancers Strong transcription Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
10 | nsv536984 | chr4:1015652-1158207 | Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
11 | nsv1005990 | chr4:1015652-1167619 | Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 22 gene(s) | inside rSNPs | diseases |
12 | nsv1000594 | chr4:1045099-1129975 | Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Flanking Active TSS Active TSS Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
13 | nsv1001165 | chr4:1051512-1129975 | Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Weak transcription Genic enhancers Strong transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
14 | nsv1012892 | chr4:1086871-1176630 | Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
15 | nsv829835 | chr4:1097586-1304239 | Enhancers Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 59 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:1094000-1105800 | Weak transcription | Ovary | ovary |
2 | chr4:1098000-1099800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr4:1098000-1099800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr4:1098000-1100200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr4:1098000-1100600 | Enhancers | Pancreas | Pancrea |
6 | chr4:1098200-1100400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
7 | chr4:1098600-1100600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr4:1099000-1099800 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr4:1099000-1100000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr4:1099200-1100000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr4:1099200-1100200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |